Bullard, Brianna L. http://orcid.org/0000-0002-6702-0079
DeBeauchamp, Jennifer
Pekarek, Matthew J.
Petro-Turnquist, Erika
Vogel, Peter http://orcid.org/0000-0002-7535-0545
Webby, Richard J. http://orcid.org/0000-0002-4397-7132
Weaver, Eric A. http://orcid.org/0000-0002-5029-0662
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (1R01AI147109, T32 AI125207)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Article History
Received: 17 December 2021
Accepted: 16 May 2022
First Online: 23 June 2022
Competing interests
: Eric A. Weaver is an inventor of the Epigraph immunogens used in this study and has a patent application in progress (Application: 62/734,791, International Application: PCT/US19/52137). Authors Brianna L. Bullard, Jennifer DeBeauchamp, Matthew J. Pekarek, Erika Petro-Turnquist, Peter Vogel, and Richard J. Webby declare no competing interests.